control group:R-chop

A multicenter, randomized, single blind, multi dose, positive drug parallel controlled phase II clinical trial to evaluate the efficacy and safety of Hisun recombinant chimeric human-mouse anti-CD20 monoclonal antibody injection combined with CHOP (Hi CHOP) regimen in previously untreated patients with diffuse large B-cell&#32

Multicenter, randomized, double-blind, and parallel active controlled trial for comparing the efficacy and safety of Haizheng recombinant human - mouse chimeric anti-CD20 monoclonal antibody injection (HS006) combined with CHOP(Hi-chop) and Rituximab combined with CHOP(R-chop) in initial treatment for patients with diffuse large B